Free tool
FAERS Monitor: Wellbutrin Sr
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020358 or its brand name (Wellbutrin Sr, Bupropion Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
79,944
Serious
42,547
53% of reports
Hospitalization
17,060
Death reported
4,101
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective7,772
- nausea6,333
- fatigue6,166
- headache5,763
- depression5,348
- pain4,701
- anxiety4,589
- dizziness4,049
- off label use4,007
- insomnia3,481
- diarrhoea3,142
- vomiting2,950
- rash2,774
- dyspnoea2,770
- weight increased2,654
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3,333 |
| 2005 | 2,895 |
| 2006 | 2,621 |
| 2007 | 2,171 |
| 2008 | 1,793 |
| 2009 | 2,373 |
| 2010 | 2,865 |
| 2011 | 2,774 |
| 2012 | 3,158 |
| 2013 | 2,680 |
| 2014 | 2,895 |
| 2015 | 4,531 |
| 2016 | 5,256 |
| 2017 | 4,228 |
| 2018 | 4,133 |
| 2019 | 4,677 |
| 2020 | 4,370 |
| 2021 | 3,921 |
| 2022 | 4,221 |
| 2023 | 3,879 |
| 2024 | 4,460 |
| 2025 | 3,839 |
| 2026 | 2,870 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,974,215 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| depressionSignal | 5,348 | 6.3 | 6.1 | 23,579 |
| anxietySignal | 4,589 | 4.3 | 4.2 | 11,569 |
| insomniaSignal | 3,481 | 3.5 | 3.4 | 6,118 |
| weight increasedSignal | 2,654 | 3.1 | 3.0 | 3,872 |
| headacheSignal | 5,763 | 2.4 | 2.4 | 4,959 |
| dizzinessSignal | 4,049 | 2.1 | 2.1 | 2,513 |
| nauseaSignal | 6,333 | 2.1 | 2.1 | 3,832 |
| fatigueSignal | 6,166 | 2.1 | 2.0 | 3,621 |
| painSignal | 4,701 | 2.0 | 2.0 | 2,479 |
| rash | 2,774 | 1.7 | 1.6 | 771 |
| vomiting | 2,950 | 1.7 | 1.6 | 776 |
| drug ineffective | 7,772 | 1.6 | 1.5 | 1,631 |
| dyspnoea | 2,770 | 1.3 | 1.2 | 183 |
| diarrhoea | 3,142 | 1.3 | 1.2 | 200 |
| off label use | 4,007 | 1.2 | 1.2 | 145 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.